You are here: Home » News-CM » Companies » News
Business Standard

Dishman Pharmaceuticals and Chemicals provides update on scheme of merger

Capital Market 

'Dishman Carbogen Amcis (merged entity) unable to file quarterly compliances with exchanges

Dishman Pharmaceuticals and Chemicals announced that pursuant to merger, the Company has been merged into CAIL and subsequently, in terms of the said Scheme, the name of Transferee Company i.e. Carbogen Amcis (India) has been changed to 'Dishman Carbogen Amcis' ("DCAL") w.e.f. 27 March, 2017.

Pursuant to the of DPCL into DCAL, securities of DPCL have been suspended by both BSE and NSE w.e.f. 30 May 2017 due to procedural reasons. The Company is in the process of listing the merged entity, DCAL on BSE and NSE.

Since the merged entity, DCAL is currently unlisted the Company is unable to file quarterly compliances as per SEBI (LODR) Regulations, 2015 with the Stock Exchanges for the quarter ended 30 June 2017.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, July 12 2017. 15:08 IST